Sesen Bio, Inc.

SESNNASDAQHealthcare

$0.63

+$0.04(+7.29%)

Market Cap$127955770

P/E Ratio—

52W High$0.965

52W Low$0.365

Avg Volume1.2M

Open$0.57

Beta0.83

Overview

Sesen Bio, Inc. (SESN) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

SESN · earnings · updated Jun 9, 2026

Latest Earnings

Q3 FY2023Report Date: Sep 30, 2023

EPS Actual

-$53.13

Revenue

$0.00B

Fiscal Period

Q3 FY2023

FY ends December

Report Date

Sep 30, 2023

After Market Close

✓ 2-Quarter EPS Beat Streak

SESN reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$3.83

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$3.83

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q3 FY2023	Sep 30, 2023	—	-$53.13	—	$0.00B	—	—
— Q2 FY2023	Jun 30, 2023	—	-$0.00	—	$0.00B	—	—
— Q2 FY2023	May 8, 2023	—	-$1.93	—	$0.00B	—	—
▲ Q1 FY2023	Feb 28, 2023	-$2.20	-$0.80	+63.6%	$0.04B	—	—
▲ Q4 FY2022	Nov 7, 2022	-$3.10	$2.00	+164.5%	$0.04B	—	—
▼ Q3 FY2022	Aug 8, 2022	-$2.60	-$3.20	-23.1%	—	—	—
▲ Q2 FY2022	May 9, 2022	-$2.00	-$0.08	+96.0%	—	—	—
▲ Q1 FY2022	Feb 28, 2022	-$1.47	$0.80	+154.4%	$0.03B	$0.05B	-42.6%

Q3 FY2023

Sep 30, 2023

EPS Actual

-$53.13

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2023

Jun 30, 2023

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2023

May 8, 2023

EPS Actual

-$1.93

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2023

Feb 28, 2023Beat

EPS Actual

-$0.80

EPS Est.

-$2.20

EPS Surpr.

+63.6%

Revenue

$0.04B

Q4 FY2022

Nov 7, 2022Beat

EPS Actual

$2.00

EPS Est.

-$3.10

EPS Surpr.

+164.5%

Revenue

$0.04B

Q3 FY2022

Aug 8, 2022Miss

EPS Actual

-$3.20

EPS Est.

-$2.60

EPS Surpr.

-23.1%

Revenue

—

Q2 FY2022

May 9, 2022Beat

EPS Actual

-$0.08

EPS Est.

-$2.00

EPS Surpr.

+96.0%

Revenue

—

Q1 FY2022

Feb 28, 2022Beat

EPS Actual

$0.80

EPS Est.

-$1.47

EPS Surpr.

+154.4%

Revenue

$0.03B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q1 FY2021	$-0.21	$-0.17	$-0.14	13
Q1 FY2015	$-0.70	$-0.58	$-0.46	11
Q1 FY2014	$-0.45	$-0.38	$-0.30	7

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q1 FY2021	$0.0B	$0.0B	$0.0B	13
Q1 FY2015	$0.0B	$0.0B	$0.0B	11
Q1 FY2014	$0.0B	$0.0B	$0.0B	7

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q3 FY2023	Sep 30, 2023	—	$0.63	—	—
— Q2 FY2023	Jun 30, 2023	—	$0.63	—	—
— Q2 FY2023	May 8, 2023	—	$0.63	—	—
▲ Q1 FY2023	Feb 28, 2023	+63.6%	$0.58	$0.58	-0.60%
▲ Q4 FY2022	Nov 7, 2022	+164.5%	$0.54	$0.55	+0.55%
▼ Q3 FY2022	Aug 8, 2022	-23.1%	$0.73	$0.73	-0.18%
▲ Q2 FY2022	May 9, 2022	+96.0%	$0.54	$0.47	-13.35%
▲ Q1 FY2022	Feb 28, 2022	+154.4%	$0.63	$0.63	+0.92%

Q3 FY2023—

Report Date

Sep 30, 2023

EPS Beat/Miss

—

Price Before

$0.63

Price After

—

Q2 FY2023—

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$0.63

Price After

—

Q2 FY2023—

Report Date

May 8, 2023

EPS Beat/Miss

—

Price Before

$0.63

Price After

—

Q1 FY2023-0.60%

Report Date

Feb 28, 2023

EPS Beat/Miss

+63.6%

Price Before

$0.58

Price After

$0.58

Q4 FY2022+0.55%

Report Date

Nov 7, 2022

EPS Beat/Miss

+164.5%

Price Before

$0.54

Price After

$0.55

Q3 FY2022-0.18%

Report Date

Aug 8, 2022

EPS Beat/Miss

-23.1%

Price Before

$0.73

Price After

$0.73

Q2 FY2022-13.35%

Report Date

May 9, 2022

EPS Beat/Miss

+96.0%

Price Before

$0.54

Price After

$0.47

Q1 FY2022+0.92%

Report Date

Feb 28, 2022

EPS Beat/Miss

+154.4%

Price Before

$0.63

Price After

$0.63

Avg Beat Reaction-3.12%

Avg Miss Reaction-0.18%

Beat Rate4 / 8 quarters

Largest Move-13.35% (Q2 FY2022)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Sesen Bio, Inc. (SESN) most recently reported earnings on September 30, 2023 for Q3 FY2023, posting EPS of $-53.13 (in line with the analyst consensus of —). SESN has beaten EPS estimates for 2 consecutive quarters. The next SESN earnings date is expected around September 1, 2026.

Each quarter, investors track SESN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SESN revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

SESN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

SESN earnings · 4 questions

Sesen Bio, Inc.'s next earnings report is expected around September 1, 2026. SESN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SESN historically reports after market close (AMC).

SESN earnings datewhen is SESN earningsSESN next earnings datewhen does SESN report earningsSESN earnings calendar

▸ Source: FMP · Sesen Bio, Inc. SEC filings · US GAAP · Sesen Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026